NCT02637700View on ClinicalTrials.gov

Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Small Fiber Neuropathy
Interventions
DRUG

Intravenous Immunoglobulin

Comparison between intravenous immunoglobulin and placebo (saline 0.9%).

DRUG

Placebo

Comparison between placebo (saline 0.9%) and intravenous immunoglobulin.

Trial Locations (1)

Unknown

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Academisch Ziekenhuis Maastricht

OTHER

NCT02637700 - Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy | Biotech Hunter | Biotech Hunter